Health ❯ Medicine ❯ Pharmaceuticals

Clinical Trials

Phase 3 Studies Obesity Treatments Alzheimer's Disease Weight Loss Drugs Weight Loss Treatments Idiopathic Pulmonary Fibrosis Hereditary Angioedema Rheumatoid Arthritis Drug Development Male Birth Control Patient Data Analysis Efficacy Studies Treatment Development Experimental Treatments Cannabis Research Breakthrough Therapy Obesity Medication Atopic Dermatitis Monoclonal Antibodies Weight Reduction Donanemab vs Leqembi Obesity Drugs Cannabis Extracts Zepbound Clinical Trials Semaglutide Trial

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

The strong showing in hard-to-treat patients signals momentum for the company’s autoimmune pipeline.

DOJ Moves State-Licensed Medical Marijuana to Schedule III Ahead of June DEA Hearing

AstraZeneca’s COPD Antibody Tozorakimab Succeeds in Two Phase 3 Trials

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial